What was Enzon Pharmaceuticals’s price range in the past 12 months?
Enzon Pharmaceuticals lowest stock price was $0.06 and its highest was $0.23 in the past 12 months.
What is Enzon Pharmaceuticals’s market cap?
Currently, no data Available
When is Enzon Pharmaceuticals’s upcoming earnings report date?
Enzon Pharmaceuticals’s upcoming earnings report date is Nov 08, 2023 which is 170 days ago.
How were Enzon Pharmaceuticals’s earnings last quarter?
Enzon Pharmaceuticals released its earnings results on Aug 03, 2023. The company reported -$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.005.
Enzon Pharmaceuticals pays a Notavailable dividend of $0.12 which represents an annual dividend yield of N/A. See more information on Enzon Pharmaceuticals dividends here
What is Enzon Pharmaceuticals’s EPS estimate?
Enzon Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enzon Pharmaceuticals have?
Enzon Pharmaceuticals has 74,214,600 shares outstanding.
What happened to Enzon Pharmaceuticals’s price movement after its last earnings report?
Enzon Pharmaceuticals reported an EPS of -$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Enzon Pharmaceuticals?
Currently, no hedge funds are holding shares in ENZN
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ.